More News

01 May 2018 Biogen and Neurimmune Announce Option Exercise for Alzheimer’s Disease Investigational Treatment Aducanumab
30 Apr 2018 4DMT and ROCHE Expand Ophthalmology Partnership to Develop and Commercialize Multiple AAV Gene Therapy Products
30 Apr 2018 WuXi Biologics to Invest €325 Million to Build Largest Biomanufacturing Facility Using Single-Use Bioreactors in Ireland
25 Apr 2018 Boehringer Ingelheim R&D Pushes to Transcend Disease Boundaries
25 Apr 2018 Entasis Therapeutics and Zai Lab Announce Exclusive License Agreement in Asia-Pacific and Global Strategic Development Collaboration for ETX2514
24 Apr 2018 Zymeworks and Celgene Expand Bispecific Antibody Collaboration
23 Apr 2018 CBT Pharmaceuticals and CrystalGenomics Announce Partnership for Co-development of Global Immuno-Oncology Therapy
23 Apr 2018 EpimAb Biotherapeutics and Zhejiang Teruisi Biopharmaceutical Announce Development Collaboration on Epimab’s FIT012 Bispecific Antibody Program
22 Apr 2018 Biogen and Ionis Expand Strategic Collaboration to Develop Drug Candidates for a Broad Range of Neurological Diseases
20 Apr 2018 UCB to expand epilepsy portfolio with strategic acquisition of Midazolam Nasal Spray from Proximagen
17 Apr 2018 Basilea licenses late-stage oncology drug candidate derazantinib from ArQule
17 Apr 2018 Cardurion Pharmaceuticals Licenses Clinical Stage Heart Failure Candidate from Astellas
17 Apr 2018 Bristol-Myers Squibb Announces Worldwide Collaboration with Janssen to Develop and Commercialize Next-Generation Cardiovascular Therapy
16 Apr 2018 Shire Announces Sale of Oncology Business to Servier for $2.4 Billion
16 Apr 2018 PhoreMost and Plexxikon collaborate to identify novel drug targets
12 Apr 2018 Bristol-Myers Squibb and Harvard Announce New Fibrosis Research Collaboration
12 Apr 2018 Mylan to Acquire the Global Marketing Rights to a Once-monthly Glatiramer Acetate Product through an Investment and Partnership with Israeli Company Mapi Pharma
12 Apr 2018 Mylan Partners with Fujifilm Kyowa Kirin Biologics to Commercialize Biosimilar to Humira® (adalimumab)
12 Apr 2018 Arbutus and Roivant Launch Genevant Sciences with Industry-Leading Platform to Develop Broad Range of RNA Therapeutics for Genetic Diseases
12 Apr 2018 GSK Signs Strategic Agreement to Transfer Rare Disease Gene Therapy Portfolio to Orchard Therapeutics
11 Apr 2018 Alexion to Acquire Wilson Therapeutics
10 Apr 2018 Promethera Biosciences Acquires Baliopharm AG to Strengthen its Therapeutic Strategy in NASH With a Unique Tumor Necrosis Factor Receptor 1 (TNF-R1) Antibody Drug Candidate
10 Apr 2018 Morphotek Announces Agreement to License its Proprietary Eribulin-Linker Payload to Bliss Biopharmaceutical Co., Ltd. for Development of a Therapeutic Antibody-Drug Conjugate (ADC)
09 Apr 2018 Novartis enters agreement to acquire AveXis Inc. for USD 8.7 bn to transform care in SMA and expand position as a gene therapy and Neuroscience leader
05 Apr 2018 Ferring Acquires Innovative Biotechnology Company and Microbiome Pioneer Rebiotix Inc.

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2017 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up